tranScrip
Sonjoy Brahma has a diverse work experience spanning over two decades. Sonjoy'smost recent role was as the Head of Clinical Programme Management at tranScrip, starting in September 2022. Prior to that, they worked at Eisai EMEA, where they held various leadership positions in clinical operations and therapy area management from 2012 to 2022. Sonjoy also served as the Head of EU Clinical Operations / Group Manager at Reckitt Benckiser from 2010 to 2012. Before that, they pursued their Masters in Business Administration at Lancaster University, during which they gained experience in biotech strategy, consulting, and supply chain management through consultancy projects. Sonjoy's career in the pharmaceutical industry began at AstraZeneca in 2002, where they held roles as a Global Clinical Project Manager/Programme Lead and a Global Project Manager in the early phase oncology department. Sonjoy also worked at CSL Recruitment & Consulting Ltd and Chiltern International in various clinical research roles. Overall, Sonjoy has demonstrated expertise in clinical operations management, programme leadership, and strategic planning in the pharmaceutical and healthcare industry.
Sonjoy Brahma completed their education with the following degrees:
- MBA from Lancaster University, studied from 2008 to 2010, with a focus on Business.
- MSc in Clinical Pharmacology from the University of Aberdeen, completed from 1998 to 1999.
- BSc in Biological Science obtained from The Manchester Metropolitan University spanning from 1993 to 1996.
Sonjoy Brahma also holds additional certifications, including "Business Development Foundations" and "GDPR Compliance: Essential Training," obtained from LinkedIn in the year 2022.
This person is not in any offices
tranScrip
tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines. We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements. Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.